SkinHealth Systems Inc. (SKIN)
| Market Cap | 89.15M -65.7% |
| Revenue (ttm) | 290.05M -6.5% |
| Net Income | -28.43M |
| EPS | -0.22 |
| Shares Out | 130.14M |
| PE Ratio | n/a |
| Forward PE | 18.14 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 369,207 |
| Open | 0.6900 |
| Previous Close | 0.6915 |
| Day's Range | 0.6733 - 0.7096 |
| 52-Week Range | 0.5506 - 2.6900 |
| Beta | 1.00 |
| Analysts | Hold |
| Price Target | 0.99 (+44.53%) |
| Earnings Date | Aug 6, 2026 |
About SKIN
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consuma... [Read more]
Financial Performance
In 2025, SkinHealth Systems's revenue was $300.79 million, a decrease of -10.02% compared to the previous year's $334.29 million. Losses were -$9.52 million, -67.29% less than in 2024.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for SKIN stock is "Hold." The 12-month stock price target is $0.99, which is an increase of 44.53% from the latest price.
News
SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth
National nine-city education series expands Hydrafacial's industry-leading provider training platform National nine-city education series expands Hydrafacial's industry-leading provider training platf...
Beauty Health price target lowered to 90c from $1 at TD Cowen
TD Cowen lowered the firm’s price target on Beauty Health (SKIN) to 90c from $1 and keeps a Hold rating on the shares. The firm updated its model following Q2…
SkinHealth Systems Proxy statement: Proxy filing
SkinHealth Systems filed a proxy statement on August 12, 2026, providing details for shareholder voting and corporate governance matters.
SkinHealth Systems Proxy statement: Proxy filing
SkinHealth Systems filed a proxy statement on August 12, 2026, providing details for shareholder voting and corporate governance matters.
SkinHealth Systems Earnings Call Transcript: Q2 2026
Revenue declined 7.8% year-over-year to $72.1 million, with equipment sales under pressure but profitability exceeding expectations due to strong gross margins and cost discipline. Strategic initiatives advanced, including a new rental program and product launches, while guidance was updated to reflect ongoing market challenges.
SkinHealth Systems Earnings release: Q2 2026
SkinHealth Systems released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
SkinHealth Systems Slides: Q2 2026
SkinHealth Systems has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
SkinHealth Systems Quarterly report: Q2 2026
SkinHealth Systems has published its Q2 2026 quarterly earnings report on August 6, 2026.
SkinHealth Systems Proxy statement: Proxy filing
SkinHealth Systems filed a proxy statement on July 31, 2026, providing details for shareholder voting and corporate governance matters.
SkinHealth Systems to Report Second Quarter 2026 Financial Results on August 6, 2026
LONG BEACH, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced it will report...
SkinHealth Systems announces FDA clearance of SkinStylus
SkinHealth Systems announced that the FDA has cleared the SkinStylus microneedling device for the improvement of the appearance of periorbital wrinkles in adults aged 22 years and older for all…
SkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
SkinStylus SteriLock MicroSystem Now the Only Microneedling Device with Indications for Facial Acne Scars, Periorbital Wrinkles, and Abdominal Scars
SkinHealth Systems Transcript: AGM 2026
The meeting covered director elections, auditor ratification, and an advisory vote on executive compensation, with all proposals recommended by the board. No questions were submitted, and voting results will be disclosed in a Form 8-K filing.
Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
An advanced, non-invasive scalp treatment with no downtime, featuring newly engineered tips and clinically proven to visibly improve scalp health and the appearance of fuller, thicker-looking hair An ...
Beauty Health price target lowered to $2 from $2.50 at Roth Capital
Roth Capital lowered the firm’s price target on Beauty Health (SKIN) to $2 from $2.50 and keeps a Buy rating on the shares. The firm is updating its model after…
SkinHealth Systems Earnings Call Transcript: Q1 2026
Q1 sales declined 6.7% year-over-year to $64.9M, but adjusted EBITDA rose 17% to $8.5M, exceeding guidance. Full-year revenue outlook was lowered to $280M-$295M due to ongoing device demand softness, while EBITDA guidance was maintained, reflecting margin strength and operational discipline.
SkinHealth Systems Earnings release: Q1 2026
SkinHealth Systems released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
SkinHealth Systems Slides: Q1 2026
SkinHealth Systems has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
SkinHealth Systems Quarterly report: Q1 2026
SkinHealth Systems has published its Q1 2026 quarterly earnings report on May 7, 2026.
SkinHealth Systems Reports First Quarter 2026 Financial Results
LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial resul...
Beauty Health price target lowered to $1 from $1.50 at Canaccord
Canaccord lowered the firm’s price target on Beauty Health (SKIN) to $1 from $1.50 and keeps a Hold rating on the shares. The firm updated its model ahead of earnings…
SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026
LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced it will report f...
SkinHealth Systems Proxy statement: Proxy filing
SkinHealth Systems filed a proxy statement on April 24, 2026, providing details for shareholder voting and corporate governance matters.
SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced the appointment ...
Beauty Health rebrands to SkinHealth Systems
Beauty Health (SKIN) Company announced a corporate rebrand to SkinHealth Systems, marking its evolution into a clinically driven, science-backed medical aesthetics company. The company will operate un...